Advanced search
Publication Cover
Biotechnology & Biotechnological Equipment Volume 37, 2023 - Issue 1
Submit an article Journal homepage
613
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Prospective study of uveitis in children with juvenile idiopathic arthritis over a 3-year period

Malina Markovaa Medical University of Sofia, Department of Ophthalmology, University Hospital Alexandrovska, Sofia, BulgariaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0001-7818-0636View further author information
ORCID Icon,
Stefan Stefanovb Department of Paediatric Rheumatology, University Children’s Hospital, Medical University of Sofia, Sofa, BulgariaView further author information
,
Albena Teltcharova-Mihaylovskab Department of Paediatric Rheumatology, University Children’s Hospital, Medical University of Sofia, Sofa, BulgariaView further author information
&
Alexander Oscara Medical University of Sofia, Department of Ophthalmology, University Hospital Alexandrovska, Sofia, BulgariaView further author information
Pages 226-230 | Received 29 Dec 2022, Accepted 09 Feb 2023, Published online: 23 Feb 2023

References

  • Heiligenhaus A, Heinz C, Edelsten C, et al. Review of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm. 2013;21(3):180–191.
  • Quartier P. Juvenile idiopathic arthritis-associated chronic uveitis: recent therapeutic approaches. J Clin Med. 2021;10(13):2934.
  • Ramanan AV, Dick AD, Jones AP, et al. Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. Engl J Med. 2017;376:1637–1646.
  • Quartier P, Baptiste A, Despert V, et al. ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis. Ann Rheum Dis. 2018;77:1003–1011.
  • Rusche H, Marrani E, Real-Fernandez F, et al. A peptide-based anti-adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis. Sci Rep. 2021;11(1):16393.
  • Carvounis PE, Herman DC, Cha S, et al. Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Graefes Arch Clin Exp Ophthalmol. 2006;244(3):281–290.
  • Heiligenhaus A, Minden K, Föll D, et al. Uveitis in juvenile idiopathic arthritis. Dtsch Arztebl Int. 2015;112(6):92–100, i.
  • Nordal E, Rypdal V, Christoffersen T, et al. Incidence and predictors of uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study. Pediatr Rheumatol Online J. 2017;15:66.
  • Angeles-Han ST, McCracken C, Yeh S, et al. Characteristics of a cohort of children with juvenile idiopathic arthritis and JIA-associated uveitis. Pediatr Rheumatol Online J. 2015;13:19.
  • Clarke SL, Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Pediatr Rheumatol Online J. 2016;14:27.
  • Kearsley-Fleet L, Klotsche J, van Straalen JW, et al. Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a collaborative analysis of 3 JIA registries. Rheumatology (Oxford). 2022;61(6):2524–2534.
  • de Boer J, Steijaert A, van den Bor R, et al. Development of macular edema and impact on visual acuity in uveitis associated with juvenile idiopathic arthritis. Ocul Immunol Inflamm. 2015;23(1):67–73.
  • Thomas J, Kuthyar S, Shantha JG, et al. Update on biologic therapies for juvenile idiopathic arthritis-associated uveitis. Ann Eye Sci. 2021;6:19.
  • Jabs DA. Immunosuppression for the uveitides. Ophthalmology. 2018;125(2):193–202.
  • Ooi KG, Galatowicz G, Calder VL, et al. Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype? Clin Med Res. 2006;4:294–309.
  • Ramanan AV, Dick AD, Benton D, et al. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE trial). Trials. 2014;15(14):5-6.
  • Calvo-Río V, Santos-Gómez M, Calvo I, et al. Anti-interleukin-6 receptor tocilizumab for severe juvenile idiopathic arthritis-associated uveitis refractory to anti-tumor necrosis factor therapy: a multicenter study of twenty-five patients. Arthritis Rheumatol. 2017;69(3):668–675.
  • Semeraro F, Arcidiacono B, Nascimbeni G, et al. Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis. Drug Des Devel Ther. 2014;8:341–348.
  • Duica I, Voinea L-M, Mitulescu C, et al. The use of biologic therapies in uveitis. Rom J Ophthalmol. 2018;62(2):105–113.
  • Rypdal V, Glerup M, Songstad NT, et al. Uveitis in juvenile idiopathic arthritis. 18-year outcome in the population-based Nordic cohort study. Ophthalmology. 2021;128(4):598–608.
  • Tappeiner C, Klotsche J, Schenck S, et al. Temporal change in prevalence and complications of uveitis associated with juvenile idiopathic arthritis: data from a cross-sectional analysis of a prospective nationwide study. Clin ExpRheumatol. 2015;33:936–e944.
  • Castagna I, Roszkowska AM, Alessandrello F, et al. Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a Centre of South Italy. Int Ophthalmol. 2020;40(2):335–342.
  • Constantin T, Foeldvari I, Anton J, et al. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Ann Rheum Dis. 2018;77(8):1107–1117.
  • Leuvenink R, Aeschlimann F, Baer W, et al. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression. Pediatr Rheumatol Online J. 2016;14(1):34.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.